NEUPATH HEALTH TO HOST ANNUAL PHYSICIAN FORUM FOCUSED ON CLINICAL EDUCATION

• Sold out event will include clinicians from NeuPath’s network and the broader medical community
• Three-day event to feature expert-led sessions on chronic pain management, emerging technologies and treatment approaches

TORONTO--(BUSINESS WIRE)-- NeuPath Health Inc. (TSXV: NPTH), (“NeuPath” or the “Company”), operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain-related medical services, today announced that it will host its annual Physician Forum from September 25 to 27, 2026, at Fairmont Le Château Montebello in Montebello, Québec.

Now in its third year, NeuPath’s annual Physician Forum has grown in participation each year and sold out for this year. This event will welcome clinicians from its network and prospective physician partners. Supported by industry sponsors, the event provides an opportunity to exchange clinical insights and strengthen connections across the broader healthcare community.

“The Physician Forum brings our clinical community together to share experiences and explore advances in chronic and musculoskeletal pain management,” said Stephen Lemieux, Chief Executive Officer of NeuPath. “It is an opportunity to strengthen relationships within our growing network, connect with new physician colleagues and share practical knowledge that supports patient care. We thank our speakers and sponsors for supporting this year’s program.”

This year’s program will feature expert-led presentations and practical sessions covering complex regional pain syndrome, myoActivation, cervicogenic and migraine headaches, artificial intelligence, and psychotherapeutic approaches to chronic pain.

Featured speakers include:

• Dr. Ryan Budwany, a triple board-certified interventional spine and pain physician whose work focuses on minimally invasive interventions, emerging technologies and responsible integration of artificial intelligence. He serves as Chief Medical Officer of PainHealth.
• Dr. Pradeep Chopra, Director of the Center for Complex Conditions and Assistant Professor at Brown Medical School, whose work focuses on complex chronic pain and associated conditions. Dr. Chopra completed training in anesthesia, critical care and pain medicine at Harvard.
• Dr. Gary Shapero, a family physician and board-certified pain practitioner specializing in headache, neck and facial pain, and a Lecturer in the University of Toronto’s Department of Family and Community Medicine.
• Dr. Greg Siren, a family physician focused on chronic pain and mobility impairment and the developer of myoActivation, a non-pharmaceutical approach to assessing and treating pain. He has led more than 50 myoActivation workshops and serves as Director of the Anatomic Medicine Foundation.
• Dr. Ed Weiss, a Kingston-based family physician with training in psychotherapeutic approaches to neuroplastic pain treatment.

To learn more about NeuPath’s annual Physician Forum, including the full program and speaker details, please view the event brochure here.

About NeuPath Health Inc.

NeuPath operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain-related medical services. NeuPath provides improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centered multidisciplinary care. Working within Canada’s publicly funded healthcare system, NeuPath delivers insured medical services to help extend the appropriate care from hospitals into the community, which are complemented by select non-insured procedures to provide a comprehensive and coordinated treatment for patients. For additional information, please visit www.neupath.com.

Forward Looking Information:

This news release contains forward-looking statements. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements reflect the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations included in this news release include, among other things, adverse market conditions, risks associated with obtaining and maintaining the necessary governmental permits and licenses related to the business of the Company, increasing competition in the market and other risks generally inherent in the chronic pain, sports medicine, concussion and workplace health services markets. A comprehensive discussion of these and other risks and uncertainties can be found in the Company’s Annual Information Form dated March 25, 2026 filed on SEDAR+ under the Company’s profile at www.sedarplus.ca.

Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to their inherent uncertainty.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS THE RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260923446389/en/

For additional Information, please contact:

Jeff Zygouras
Chief Financial Officer
[email protected]
(905) 858-1368

Source: NeuPath Health Inc.

You May Also Be Interested In

• WSFS Bank and Bryn Mawr Trust Expand into Lancaster; Deepening Regional Wealth, Private Banking, and Lending Services
• Assay Genie Publishes Research Pulse 2026 on Alzheimer’s Blood Tests, Inflammation Markers and Lactylation
• Iverson CDJR Huron Highlights Online Service Scheduling for South Dakota Drivers